Subclinical hypercortisolism: A state, a syndrome, or a disease?

European Journal of Endocrinology

Volumn 173, Issue 4, 2015, Pages M61-M71

  Di Dalmazi, Guido ^a   Pasquali, Renato ^b   Beuschlein, Felix ^a   Reincke, Martin ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CARDIOVASCULAR RISK; COMORBIDITY; COMPUTER ASSISTED TOMOGRAPHY; CONFERENCE PAPER; DISEASE ASSOCIATION; ECHOGRAPHY; HUMAN; HYPERCORTISOLISM; HYPERTENSION; INCIDENCE; LIPID STORAGE; LONGITUDINAL STUDY; METABOLIC DISORDER; NON INSULIN DEPENDENT DIABETES MELLITUS; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SPINE FRACTURE; SUBCLINICAL HYPERCORTISOLISM; ADRENAL TUMOR; ASYMPTOMATIC DISEASE; CARDIOVASCULAR DISEASES; COMPLICATION; CUSHING SYNDROME; DIABETES MELLITUS, TYPE 2; HYPOPHYSIS ADRENAL SYSTEM; HYPOTHALAMUS HYPOPHYSIS SYSTEM; METABOLISM; OBESITY, ABDOMINAL; OSTEOPOROTIC FRACTURES; SPINAL FRACTURES;

ADRENAL GLAND NEOPLASMS; ASYMPTOMATIC DISEASES; CARDIOVASCULAR DISEASES; CUSHING SYNDROME; DIABETES MELLITUS, TYPE 2; HUMANS; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; OBESITY, ABDOMINAL; OSTEOPOROTIC FRACTURES; PITUITARY-ADRENAL SYSTEM; SPINAL FRACTURES;

EID: 84942773533     PISSN: 08044643     EISSN: 1479683X     Source Type: Journal    
DOI: 10.1530/EJE-15-0272     Document Type: Conference Paper

References (69)

1. Mantero F, Terzolo M, Arnaldi G, Osella G, Masini AM, Alì A, Giovagnetti M, Opocher G & Angeli A. A survey on adrenal incidentaloma in Italy. Study Group on Adrenal Tumors of the Italian Society of Endocrinology. Journal of Clinical Endocrinology and Metabolism 2000 85 637-644. (doi:10.1210/jcem.85.2.6372.
2. Terzolo M, Pia A, Alì A, Osella G, Reimondo G, Bovio S, Daffara F, Procopio M, Paccotti P, Borretta G et al. Adrenal incidentaloma: a new cause of the metabolic syndrome? Journal of Clinical Endocrinology and Metabolism 2002 87 998-1003. (doi:10.1210/jcem.87.3.8277.
3. Chiodini I. Clinical review: diagnosis and treatment of subclinical hypercortisolism. Journal of Clinical Endocrinology and Metabolism 2011 96 1223-1236. (doi:10.1210/jc.2010-2722.
4. Ilias I, Sahdev A, Reznek RH, Grossman AB & Pacak K. The optimal imaging of adrenal tumours: a comparison of different methods. Endocrine-Related Cancer 2007 14 587-599. (doi:10.1677/ERC-07-0045.
5. Hennings J, Hellman P, Ahlström H & Sundin A. Computed tomography, magnetic resonance imaging and 11C-metomidate positron emission tomography for evaluation of adrenal incidentalomas. European Journal of Radiology 2009 69 314-323. (doi:10.1016/j.ejrad.2007.10.024.
6. Blake MA, Cronin CG & Boland GW. Adrenal imaging. AJR. American Journal of Roentgenology 2010 194 1450-1460. doi:10.2214/AJR.10.4547).
7. Olsen H, Nordenström E, Bergenfelz A, Nyman U, Valdemarsson S & Palmqvist E. Subclinical hypercortisolismand CT appearance in adrenal incidentalomas: a multicenter study from Southern Sweden. Endocrine 2012 42 164-173. doi:10.1007/s12020-012-9622-2.
8. Kohara K. Sarcopenic obesity in aging population: current status and future directions for research. Endocrine 2014 45 15-25. doi:10.1007/s12020-013-9992-0.
9. Schneider HJ, Dimopoulou C, Stalla GK, Reincke M & Schopohl J. Discriminatory value of signs and symptoms in Cushing's syndrome revisited: what has changed in 30 years? Clinical Endocrinology 2013 78 153-154. (doi:10.1111/j.1365-2265.2012.04488.x.
10. NIH state-of-the-science statement on management of the clinically inapparent adrenal mass ("incidentaloma"). NIH Consensus and State-of-the-Science Statements 2002 19 1-25.
11. Nieman LK, Biller BM, Findling JW, Newell-Price J, Savage MO, Stewart PM & Montori VM. The diagnosis of Cushing's syndrome: an Endocrine Society Clinical Practice Guideline. Journal of Clinical Endocrinology and Metabolism 2008 93 1526-1540. doi:10.1210/jc.2008-0125.
12. Tabarin A, Bardet S, Bertherat J, Dupas B, Chabre O, Hamoir E, Laurent F, Tenenbaum F, Cazalda M, Lefebvre H et al. French Society of Endocrinology Consensus. Exploration and management of adrenal incidentalomas. French Society of Endocrinology Consensus. Annales d'Endocrinologie 2008 69 487-500. (doi:10.1016/j.ando.2008.09.003.
13. Zeiger MA, Thompson GB, Duh QY, Hamrahian AH, Angelos P, Elaraj D, Fishman E & Kharlip J. American Association of Clinical Endocrinologists; American Association of Endocrine Surgeons. The American Association of Clinical Endocrinologists and American Association of Endocrine Surgeons medical guidelines for the management of adrenal incidentalomas. Endocrine Practice 2009 15 (Suppl 1) 1-20. (doi:10.4158/EP.15.S1.1.
14. Terzolo M, Stigliano A, Chiodini I, Loli P, Furlani L, Arnaldi G, Reimondo G, Pia A, Toscano V, Zini M et al. Italian Association of Clinical Endocrinologists. AME position statement on adrenal incidentaloma. European Journal Endocrinology 2011 164 851-870. (doi:10.1530/EJE-10-1147.
15. Shen J, Sun M, Zhou B & Yan J. Nonconformity in the clinical practice guidelines for subclinical Cushing's syndrome: which guidelines are trustworthy? European Journal Endocrinology 2014 171 421-431. (doi:10.1530/EJE-14-0345.
16. Morelli V, Masserini B, Salcuni AS, Eller-Vainicher C, Savoca C, Viti R, Coletti F, Guglielmi G, Battista C, Iorio L et al. Subclinical hypercortisolism: correlation between biochemical diagnostic criteria and clinical aspects. Clinical Endocrinology 2010 73 161-166. (doi:10.1111/j.1365-2265.2010.03794.x.
17. Piaditis GP, Kaltsas GA, Androulakis II, Gouli A, Makras P, Papadogias D, Dimitriou K, Ragkou D, Markou A, Vamvakidis K et al. High prevalence of autonomous cortisol and aldosterone secretion from adrenal adenomas. Clinical Endocrinology 2009 71 772-778. (doi:10.1111/j.1365-2265.2009.03551.x.
18. Androulakis II, Kaltsas G, Piaditis G & Grossman AB. The clinical significance of adrenal incidentalomas. European Journal of Clinical Investigation 2011 41 552-560. (doi:10.1111/j.1365-2362.2010.02436.x.
19. Rizzoni D, Porteri E, De Ciuceis C, Rodella LF, Paiardi S, Rizzardi N, Platto C, Boari GE, Pilu A, Tiberio GA et al. Hypertrophic remodeling of subcutaneous small resistance arteries in patients with Cushing's syndrome. Journal of Clinical Endocrinology and Metabolism 2009 94 5010-5018. (doi:10.1210/jc.2009-1588.
20. Mihailidou AS, Loan Le TY, Mardini M & Funder JW. Glucocorticoids activate cardiac mineralocorticoid receptors during experimental myocardial infarction. Hypertension 2009 54 1306-1312. (doi:10.1161/HYPERTENSIONAHA.109.136242.
21. De-Leo M, Pivonello R, Auriemma RS, Cozzolino A, Vitale P, Simeoli C, De Martino MC, Lombardi G & Colao A. Cardiovascular disease in Cushing's syndrome: heart versus vasculature. Neuroendocrinology 2010 92 (Suppl 1) 50-54. (doi:10.1159/000318566.
22. Anagnostis P, Athyros VG, Tziomalos K, Karagiannis A & Mikhailidis DP. Clinical review: the pathogenetic role of cortisol in the metabolic syndrome: a hypothesis. Journal of Clinical Endocrinology and Metabolism 2009 94 2692-2701. (doi:10.1210/jc.2009-0370.
23. Iacobone M, Citton M, Scarpa M, Viel G, Boscaro M& Nitti D. Systematic review of surgical treatment of subclinical Cushing's syndrome. British Journal of Surgery 2015 102 318-330. (doi:10.1002/bjs.9742.
24. Ivović M, Marina LV, Vujović S, Tančić-Gajić M, Stojanović M, Radonjić NV, Gajić M, Soldatović I & Micić D. Nondiabetic patients with either subclinical Cushing's or nonfunctional adrenal incidentalomas have lower insulin sensitivity than healthy controls: clinical implications. Metabolism 2013 62 786-792. (doi:10.1016/j.metabol.2012.12.006.
25. Androulakis II, Kaltsas GA, Kollias GE, Markou AC, Gouli AK, Thomas DA, Alexandraki KI, Papamichael CM, Hadjidakis DJ & Piaditis GP. Patients with apparently nonfunctioning adrenal incidentalomas may be at increased cardiovascular risk due to excessive cortisol secretion. Journal of Clinical Endocrinology and Metabolism 2014 99 2754-2762. (doi:10.1210/jc.2013-4064.
26. Giordano R, Guaraldi F, Berardelli R, Karamouzis I, D'Angelo V, Marinazzo E, Picu A, Ghigo E & Arvat E. Glucose metabolism in patients with subclinical Cushing's syndrome. Endocrine 2012 41 415-423. (doi:10.1007/s12020-012-9628-9.
27. Debono M, Prema A, Hughes TJ, Bull M, Ross RJ & Newell-Price J. Visceral fat accumulation and postdexamethasone serum cortisol levels in patients with adrenal incidentaloma. Journal of Clinical Endocrinology and Metabolism 2013 98 2383-2391. (doi:10.1210/jc.2012-4276.
28. Papanastasiou L, Pappa T, Samara C, Apostolopoulou G, Tsiavos V, Markou A, Alexandraki K, Piaditis G, Chrousos G & Kaltsas G. Nonalcoholic fatty liver disease in subjects with adrenal incidentaloma. European Journal of Clinical Investigation 2012 42 1165-1172. (doi:10.1111/j.1365-2362.2012.02707.x).
29. Masserini B, Morelli V, Palmieri S, Eller-Vainicher C, Zhukouskaya V, Cairoli E, Orsi E, Beck-Peccoz P, Spada A & Chiodini I. Lipid abnormalities in patients with adrenal incidentalomas: role ofsubclinical hypercortisolism and impaired glucose metabolism. Journal of Endocrinological Investigation 2015 38 623-628. (doi:10.1007/s40618-014-0232-0.
30. Tóth M & Grossman A. Glucocorticoid-induced osteoporosis: lessons from Cushing's syndrome. Clinical Endocrinology 2013 79 1-11. (doi:10.1111/cen.12189.
31. Chiodini I, Guglielmi G, Battista C, Carnevale V, Torlontano M, Cammisa M, Trischitta V & Scillitani A. Spinal volumetric bone mineral density and vertebral fractures in female patients with adrenal incidentalomas: the effects of subclinical hypercortisolism and gonadal status. Journal of Clinical Endocrinology and Metabolism 2004 89 2237- 2241. (doi:10.1210/jc.2003-031413.
32. Tauchmanovà L, Pivonello R, De-Martino MC, Rusciano A, De-Leo M, Ruosi C, Mainolfi C, Lombardi G, Salvatore M & Colao A. Effects of sex steroids on bone in women with subclinical or overt endogenous hypercortisolism. European Journal Endocrinology 2007 157 359-366. (doi:10.1530/EJE-07-0137.
33. Chiodini I, Viti R, Coletti F, Guglielmi G, Battista C, Ermetici F, Morelli V, Salcuni A, Carnevale V, Urbano F et al. Eugonadal male patients with adrenal incidentalomas and subclinical hypercortisolism have increased rate of vertebral fractures. Clinical Endocrinology 2009 70 208-213. (doi:10.1111/j.1365-2265.2008.03310.x.
34. Chiodini I, Morelli V, Masserini B, Salcuni AS, Eller-Vainicher C, Viti R, Coletti F, Guglielmi G, Battista C, Carnevale V et al. Bone mineral density, prevalence of vertebral fractures, and bone quality in patients with adrenal incidentalomas with and without subclinical hypercortisolism: an Italian multicenter study. Journal of Clinical Endocrinology and Metabolism 2009 94 3207-3214(doi:10.1210/jc.2009-0468.
35. Morelli V, Eller-Vainicher C, Salcuni AS, Coletti F, Iorio L, Muscogiuri G, Della Casa S, Arosio M, Ambrosi B, Beck-Peccoz P et al. Risk of new vertebral fractures in patients with adrenal incidentaloma with and without subclinical hypercortisolism: a multicenter longitudinal study. Journal of Bone and Mineral Research 2011 26 1816-1821. (doi:10.1002/jbmr.398.
36. Di-Dalmazi G, Vicennati V, Rinaldi E, Morselli-Labate AM, Giampalma E, Mosconi C, Pagotto U & Pasquali R. Progressively increased patterns of subclinical cortisol hypersecretion in adrenal incidentalomas differently predict major metabolic and cardiovascular outcomes: a large cross-sectional study. European Journal Endocrinology 2012 166 669-677. (doi:10.1530/EJE-11-1039.
37. Miller WL & Auchus RJ. The molecular biology, biochemistry, and physiology of human steroidogenesis and its disorders. Endocrine Reviews 2011 32 81-151. (doi:10.1210/er.2010-0013.
38. Ghebre MA, Hart DJ, Hakim AJ, Kato BS, Thompson V, Arden NK, Spector TD & Zhai G. Association between DHEAS and bone loss in postmenopausal women: a 15-year longitudinal population-based study. Calcified Tissue International 2011 89 295-302. (doi:10.1007/s00223-011-9518-9.
39. Garnero P, Sornay-Rendu E, Claustrat B & Delmas PD. Biochemical markers of bone turnover, endogenous hormones and the risk of fractures in postmenopausal women: the OFELY study. Journal of Bone and Mineral Research 2000 15 1526-1536. (doi:10.1359/jbmr.2000.15.8.1526.
40. Zofková I, Bahbouh R & Hill M. The pathophysiological implications of circulating androgens on bone mineral density in a normal female population. Steroids 2000 65 857-861. (doi:10.1016/S0039-128X(00)00136-7.
41. Guthrie JR, Lehert P, Dennerstein L, Burger HG, Ebeling PR & Wark JD. The relative effect of endogenous estradiol and androgens on menopausal bone loss: a longitudinal study. Osteoporosis International 2004 15 881-886. doi:10.1007/s00198-004-1624-3.
42. Baulieu EE, Thomas G, Legrain S, Lahlou N, Roger M, Debuire B, Faucounau V, Girard L, Hervy MP, Latour F et al. Dehydroepiandrosterone (DHEA) DHEA sulfate, and aging: contribution of the DHEAge Study to a sociobiomedical issue. PNAS 2000 97 4279-4284. (doi:10.1073/pnas.97.8.4279.
43. Nair KS, Rizza RA, O'Brien P, Dhatariya K, Short KR, Nehra A, Vittone JL, Klee GG, Basu A, Basu R et al. DHEA in elderly women and DHEA or testosterone in elderly men. New England Journal of Medicine 2006 355 1647-1659. doi:10.1056/NEJMoa054629.
44. Tauchmanovà L, Rossi R, Biondi B, Pulcrano M, Nuzzo V, Palmieri EA, Fazio S & Lombardi G. Patients with subclinical Cushing's syndrome due to adrenal adenoma have increased cardiovascular risk. Journal of Clinical Endocrinology and Metabolism 2002 87 4872-4878. (doi:10.1210/jc.2001-011766.
45. Di-Dalmazi G, Vicennati V, Garelli S, Casadio E, Rinaldi E, Giampalma E, Mosconi C, Golfieri R, Paccapelo A, Pagotto U et al. Cardiovascular events and mortality in patients with adrenal incidentalomas that are either non-secreting or associated with intermediate phenotype or subclinical Cushing's syndrome: a 15-year retrospective study. Lancet. Diabetes & Endocrinology 2014 2 396-405. (doi:10.1016/S2213-8587(13)70211-0.
46. Morelli V, Reimondo G, Giordano R, Della Casa S, Policola C, Palmieri S, Salcuni AS, Dolci A, Mendola M, Arosio M et al. Long-term follow-up in adrenal incidentalomas: an Italian multicenter study. Journal of Clinical Endocrinology and Metabolism 2014 99 827-834. (doi:10.1210/jc.2013-3527).
47. Debono M, Bradburn M, Bull M, Harrison B, Ross RJ & Newell-Price J. Cortisol as a marker for increased mortality in patients with incidental adrenocortical adenomas. Journal of Clinical Endocrinology and Metabolism 2014 99 4462-4470. (doi:10.1210/jc.2014-3007.
48. Barry MK, van-Heerden JA, Farely DR, Grant CS, Thompson GB & Ilstrup DM. Can adrenal incidentalomas be safely observed? World Journal of Surgery 1998 22 599-604. (doi:10.1007/s002689900441.
49. Sirén J, Tervahartiala P, Sivula A & Haapiainen R. Natural course of adrenal incidentalomas: seven-year follow-up study. World Journal of Surgery 2000 24 579-582. (doi:10.1007/s002689910095.
50. Brossaud J, Ducint D & Corcuff JB. Urinary glucocorticoid metabolites: biomarkers to classify adrenal incidentalomas? Clinical Endocrinology 2015. In press. (doi:10.1111/cen.12717.
51. Rossi R, Tauchmanova L, Luciano A, Di-Martino M, Battista C, Del-Viscovo L, Nuzzo V & Lombardi G. Subclinical Cushing's syndrome in patients with adrenal incidentaloma: clinical and biochemical features. Journal of Clinical Endocrinology and Metabolism 2000 85 1440-1448. (doi:10.1210/jcem.85.4.6515.
52. Terzolo M, Bovio S, Pia A, Conton PA, Reimondo G, Dall'Asta C, Bemporad D, Angeli A, Opocher G, Mannelli M et al. Midnight serum cortisol as a marker of increased cardiovascular risk in patients with a clinically inapparent adrenal adenoma. European Journal Endocrinology 2005 153 307-315. (doi:10.1530/eje.1.01959.
53. Erbil Y, Ademoʇlu E, Ozbey N, Barbaros U, Yanik BT, Salmaslioʇlu A, Bozbora A & Ozarmaʇan S. Evaluation of the cardiovascular risk in patients with subclinical Cushing syndrome before and after surgery. World Journal of Surgery 2006 30 1665-1671. (doi:10.1007/s00268-005-0681-x.
54. Masserini B, Morelli V, Bergamaschi S, Ermetici F, Eller-Vainicher C, Barbieri AM, Maffini MA, Scillitani A, Ambrosi B, Beck-Peccoz P et al. The limited role of midnight salivary cortisol levels in the diagnosis of subclinical hypercortisolism in patients with adrenal incidentaloma. European Journal Endocrinology 2009 160 87-92. (doi:10.1530/EJE-08-0485.
55. Toniato A, Merante-Boschin I, Opocher G, Pelizzo MR, Schiavi F & Ballotta E. Surgical versus conservative management for subclinical Cushing syndrome in adrenal incidentalomas: a prospective randomized study. Annals of Surgery 2009 249 388-391. (doi:10.1097/SLA.0b013e31819a47d2).
56. Vassilatou E, Vryonidou A, Michalopoulou S, Manolis J, Caratzas J, Phenekos C & Tzavara I. Hormonal activity of adrenal incidentalomas: results from a long-term follow-up study. Clinical Endocrinology 2009 70 674-679. (doi:10.1111/j.1365-2265.2008.03492.x.
57. Chiodini I, Morelli V, Salcuni AS, Eller-Vainicher C, Torlontano M, Coletti F, Iorio L, Cuttitta A, Ambrosio A, Vicentini L et al. Beneficialmetabolic effects of prompt surgical treatment in patients with an adrenal incidentaloma causing biochemical hypercortisolism. Journal of Clinical Endocrinology and Metabolism 2010 95 2736-2745. doi:10.1210/jc.2009-2387.
58. Giordano R, Marinazzo E, Berardelli R, Picu A, Maccario M, Ghigo E & Arvat E. Long-term morphological, hormonal, and clinical follow-up in a single unit on 118 patients with adrenal incidentalomas. European Journal Endocrinology 2010 162 779-785. (doi:10.1530/EJE-09-0957.
59. Eller-Vainicher C, Morelli V, Salcuni AS, Battista C, Torlontano M, Coletti F, Iorio L, Cairoli E, Beck-Peccoz P, Arosio M et al. Accuracy of several parameters of hypothalamic-pituitary-adrenal axis activity in predicting before surgery the metabolic effects of the removal of an adrenal incidentaloma. European Journal Endocrinology 2010 163 925-935. (doi:10.1530/EJE-10-0602.
60. Alesina PF, Hommeltenberg S, Meier B, Petersenn S, Lahner H, Schmid KW, Mann K & Walz MK. Posterior retroperitoneoscopic adrenalectomy for clinical and subclinical Cushing's syndrome. World Journal of Surgery 2010 34 1391-1397. doi:10.1007/s00268-010-0453-0.
61. Akaza I, Yoshimoto T, Iwashima F, Nakayama C, Doi M, Izumiyama H & Hirata Y. Clinical outcome of subclinical Cushing's syndrome after surgical and conservative treatment. Hypertension Research 2011 34 1111-1115. (doi:10.1038/hr.2011.90.
62. Iacobone M, Citton M, Viel G, Boetto R, Bonadio I, Mondi I, Tropea S, Nitti D & Favia G. Adrenalectomy may improve cardiovascular and metabolic impairment and ameliorate quality of life in patients with adrenal incidentalomas and subclinical Cushing's syndrome. Surgery 2012 152 991-997. (doi:10.1016/j.surg.2012.08.054.
63. Morelli V, Palmieri S, Salcuni AS, Eller-Vainicher C, Cairoli E, Zhukouskaya V, Scillitani A, Beck-Peccoz P & Chiodini I. Bilateral and unilateral adrenal incidentalomas: biochemical and clinical characteristics. European Journal Endocrinology 2013 168 235-241. (doi:10.1530/EJE-12-0777.
64. Perysinakis I, Marakaki C, Avlonitis S, Katseli A, Vassilatou E, Papanastasiou L, Piaditis G & Zografos GN. Laparoscopic adrenalectomy in patients with subclinical Cushing syndrome. Surgical Endoscopy 2013 27 2145-2148. doi:10.1007/s00464-012-2730-5.
65. Palmieri S, Morelli V, Polledri E, Fustinoni S, Mercadante R, Olgiati L, Eller Vainicher C, Cairoli E, Zhukouskaya VV & Beck-Peccoz P. The role of salivary cortisol measured by liquid chromatographytandem mass spectrometry in the diagnosis of subclinical hypercortisolism. European Journal Endocrinology 2013 168 289-296. (doi:10.1530/EJE-12-0803.
66. Vassilatou E, Vryonidou A, Ioannidis D, Paschou SA, Panagou M & Tzavara I. Bilateral adrenal incidentalomas differ from unilateral adrenal incidentalomas in subclinical cortisol hypersecretion but not in potential clinical implications. European Journal Endocrinology 2014 171 37-45. (doi:10.1530/EJE-13-0848.
67. Kawate H, Kohno M, Matsuda M, Akehi Y, Tanabe M, Horiuchi T, Ohnaka K, Nomura M, Yanase T & Takayanagi R. Long-term study of subclinical Cushing's syndrome shows high prevalence of extraadrenal malignancy in patients with functioning bilateral adrenal tumors. Endocrine Journal 2014 61 1205-1212. (doi:10.1507/endocrj.EJ14-0155.
68. Kim BY, Chun AR, Kim KJ, Jung CH, Kang SK, Mok JO & Kim CH. Clinical characteristics and metabolic features of patients with adrenal incidentalomas with or without subclinical Cushing's syndrome. Endocrinology and Metabolism 2014 29 457-463. (doi:10.3803/EnM.2014.29.4.457.
69. Ricciato MP, Di-Donna V, Perotti G, Pontecorvi A, Bellantone R & Corsello SM. The role of adrenal scintigraphy in the diagnosis of subclinical Cushing's syndrome and the prediction of post-surgical hypoadrenalism. World Journal of Surgery 2014 38 1328-1335.